product summary
company name :
Cell Signaling Technology
product type :
antibody
product name :
Phospho-Etk (Tyr40) Antibody
catalog :
3211S
quantity :
100 ul
price :
274 USD
clonality :
polyclonal
host :
rabbit
antigen modification :
phosphorylated
reactivity :
human
application :
western blot, immunoprecipitation
citations: 2
Published Application/Species/DilutionReference
  • western blot; human
Guo W, Liu R, Bhardwaj G, Yang J, Changou C, Ma A, et al. Targeting Btk/Etk of prostate cancer cells by a novel dual inhibitor. Cell Death Dis. 2014;5:e1409 pubmed publisher
Mathews L, Hurt E, Zhang X, Farrar W. Epigenetic regulation of CpG promoter methylation in invasive prostate cancer cells. Mol Cancer. 2010;9:267 pubmed publisher
product information
SKU :
3211S
Product-Name :
Phospho-Etk (Tyr40) Antibody
Size :
100 ul
Price-(USD) :
274 USD
Species-x-Reactivity :
H
Applications :
Immunoprecipitation
Product-Category :
RTK
Shipping-Temp :
AMBIENT
Storage-Temp :
-20°C
Product-Type :
Polyclonal Antibody
MW :
76
Host :
Rabbit
Target :
Etk/BMX (Tyr40) phosphate
Primary-Protein :
Etk
Alt-Names :
BMX,BMX non-receptor tyrosine kinase,Bone marrow tyrosine kinase gene in chromosome X protein,Cytoplasmic tyrosine-protein kinase BMX,ETK,Epithelial and endothelial tyrosine kinase,Etk/Bmx cytosolic tyrosine kinase,NTK38,NTK38 tyrosine kinase,PSCTK2,PSCTK3
company information
Cell Signaling Technology
3 Trask Lane
Danvers, MA 01923
info@cellsignal.com
www.cellsignal.com
8776162355
headquarters: USA
Established in Beverly, MA in 1999, Cell Signaling Technology (CST) is a privately-owned company with over 400 employees worldwide. We are dedicated to providing innovative research tools that are used to help define mechanisms underlying cell function and disease. Since its inception, CST has become the world leader in the production of the highest quality activation-state and total protein antibodies utilized to expand knowledge of cell signaling pathways. Our mission is to deliver the world's highest quality research tools that accelerate progress in biological research and personalized medicine.